Deutsch English Français

Contact

EP0782447

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0782447

EP0782447 - USE OF PROSTAGLANDINS FOR THE MANUFACTURE OF A MEDICAMENT FOR PREVENTION AND TREATMENT OF SECONDARY CATARACT [Right-click to bookmark this link]
Former [1997/28]	METHOD AND MEANS FOR PREVENTION AND TREATMENT OF SECONDARY CATARACT
	[2001/10]
Status	No opposition filed within time limit Status updated on 11.01.2003 Database last updated on 03.09.2024
Most recent event Tooltip	06.08.2004	Lapse of the patent in a contracting state New state(s): LU	published on 22.09.2004 [2004/39]
Applicant(s)	For all designated states Synphora AB Dag Hammarskjölds väg 10A 751 83 Uppsala / SE
	[2002/04]
Former [1999/35]	For all designated states Synphora AB c/o Stjernchantz, Villavägen 1 B 752 38 Uppsala / SE
Former [1998/32]	For all designated states Pharmacia & Upjohn Aktiebolag 112 87 Stockholm / SE
Former [1997/28]	For all designated states Pharmacia & Upjohn Aktiebolag 171 97 Stockholm / SE
Inventor(s)	01 / STJERNSCHANTZ, Johan Villavägen 1B S-752 38 Uppsala / SE
	02 / RESUL, Bahram Vitkälsgatan 112 S-754 49 Uppsala / SE
	[1997/28]
Representative(s)	Larfeldt, Helene, et al Bergensträhle & Lindvall AB P.O. Box 17704 118 93 Stockholm / SE
	[N/P]
Former [2002/04]	Larfeldt, Helene, et al Bergensträhle & Lindvall AB P.O. Box 17704 118 93 Stockholm / SE
Former [1999/35]	Hyltner, Jan-Olof, et al Göteborgs Patentbyra Dahls AB Box 606 182 16 Danderyd / SE
Former [1999/22]	Hyltner, Jan-Olof Göteborgs Patentbyra Dahls AB Box 606 182 16 Danderyd / SE
Application number, filing date	95932999.6	19.09.1995
	[1997/28]
	WO1995SE01058
Priority number, date	SE19940003160	21.09.1994 Original published format: SE 9403160
	[1997/28]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9609054
	Date:	28.03.1996
	Language:	EN
	[1996/14]
	Type:	A1 Application with search report
	No.:	EP0782447
	Date:	09.07.1997
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 28.03.1996 takes the place of the publication of the European patent application.
	[1997/28]
	Type:	B1 Patent specification
	No.:	EP0782447
	Date:	27.02.2002
	Language:	EN
	[2002/09]
Search report(s)	International search report - published on:	SE	28.03.1996
Classification	IPC:	A61K31/5575	[2001/10]
	CPC:	A61K31/5575 (EP,US); A61P27/02 (EP); A61P27/12 (EP)
	Former IPC [1997/28]	A61K31/557
Designated contracting states	AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1997/28]
Title	German:	VERWENDUNG VON PROSTAGLANDINEN ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR PRÄVENTION UND BEHANDLUNG DES SEKUNDÄREN KATARAKTS	[2001/10]
	English:	USE OF PROSTAGLANDINS FOR THE MANUFACTURE OF A MEDICAMENT FOR PREVENTION AND TREATMENT OF SECONDARY CATARACT	[2001/10]
	French:	UTILISATION DE PROSTAGANDINES POUR LA FABRICATION D' UN MEDICAMENT POUR LA PREVENTION ET LE TRAITEMENT DE LA CATARACTE SECONDAIRE	[2001/10]
	Former [1997/28]	VERFAHREN UND MITTEL ZUR PRÄVENTION UND BEHANDLUNG DES SEKUNDÄREN KATARAKTS
	Former [1997/28]	METHOD AND MEANS FOR PREVENTION AND TREATMENT OF SECONDARY CATARACT
	Former [1997/28]	PROCEDE ET MOYEN DE PREVENTION ET DE TRAITEMENT DE LA CATARACTE SECONDAIRE
Entry into regional phase	13.03.1997	National basic fee paid
	13.03.1997	Designation fee(s) paid
	13.03.1997	Examination fee paid
Examination procedure	26.03.1996	Request for preliminary examination filed International Preliminary Examining Authority: SE
	13.03.1997	Examination requested [1997/28]
	27.03.2000	Despatch of a communication from the examining division (Time limit: M04)
	21.07.2000	Reply to a communication from the examining division
	01.03.2001	Despatch of communication of intention to grant (Approval: No)
	02.07.2001	Despatch of communication of intention to grant (Approval: later approval)
	27.07.2001	Communication of intention to grant the patent
	04.10.2001	Fee for grant paid
	04.10.2001	Fee for publishing/printing paid
Opposition(s)	28.11.2002	No opposition filed within time limit [2003/09]
Fees paid	Renewal fee
	10.09.1997	Renewal fee patent year 03
	09.09.1998	Renewal fee patent year 04
	29.09.1999	Renewal fee patent year 05
	28.09.2000	Renewal fee patent year 06
	20.09.2001	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AT	27.02.2002
	BE	27.02.2002
	GR	27.02.2002
	NL	27.02.2002
	DK	27.05.2002
	PT	27.05.2002
	SE	27.05.2002
	IE	19.09.2002
	LU	19.09.2002
	[2004/39]
Former [2003/45]	AT	27.02.2002
	BE	27.02.2002
	GR	27.02.2002
	NL	27.02.2002
	DK	27.05.2002
	PT	27.05.2002
	SE	27.05.2002
	IE	19.09.2002
Former [2003/42]	AT	27.02.2002
	BE	27.02.2002
	GR	27.02.2002
	NL	27.02.2002
	PT	27.05.2002
	SE	27.05.2002
	IE	19.09.2002
Former [2003/19]	AT	27.02.2002
	BE	27.02.2002
	GR	27.02.2002
	NL	27.02.2002
	PT	27.05.2002
	SE	27.05.2002
Former [2003/09]	AT	27.02.2002
	BE	27.02.2002
	NL	27.02.2002
	PT	27.05.2002
	SE	27.05.2002
Former [2003/06]	BE	27.02.2002
	NL	27.02.2002
	PT	27.05.2002
	SE	27.05.2002
Former [2002/37]	SE	27.05.2002
Cited in	International search	[X]EP0097023 (ONO PHARMACEUTICAL CO [JP]);
		[X]EP0242580 (UNIV COLUMBIA [US]);
		[A]EP0453127 (UENO SEIYAKU OYO KENKYUJO KK [JP])

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p